🎁 Black Friday: up to 50% off of annual plans
Captor Therapeutics Spolka Akcyjna (WSE:CTX)
Poland flag Poland · Delayed Price · Currency is PLN
52.00
-0.20 (-0.38%)
Nov 20, 2026, 4:59 PM CET

WSE:CTX Income Statement

Millions PLN. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
3.334.6615.8313.29.163.99
Revenue Growth
-56.05%-70.55%19.88%44.15%129.75%-
Cost of Revenue
0.511.455.236.32.090.74
Gross Profit
2.823.2210.66.97.073.25
Selling, General & Admin
11.1411.1411.4616.1424.0730.68
Research & Development
45.2945.2943.970.8944.1623.12
Other Operating Expenses
-7.82-9.57-5.79-7.11-22.79-17.71
Operating Expenses
48.6146.8549.5679.9245.4436.09
Operating Income
-45.78-43.63-38.97-73.02-38.36-32.84
Interest Expense
-0.28-0.28-0.39-0.27-0.32-0.4
Interest & Investment Income
1.821.821.043.083.13-
Currency Exchange Gain (Loss)
0.030.03-0.07-0.27-0.08-0.06
Other Non Operating Income (Expenses)
-2.18-0.01-0.05-0.05-0.26-0.41
EBT Excluding Unusual Items
-46.39-42.07-38.43-70.53-35.89-33.7
Gain (Loss) on Sale of Assets
0.070.07----
Asset Writedown
-----1.13
Pretax Income
-46.32-42-38.43-70.53-35.89-32.57
Income Tax Expense
0.03--0.06--
Net Income
-46.35-42-38.43-70.58-35.89-32.57
Net Income to Common
-46.35-42-38.43-70.58-35.89-32.57
Net Income Growth
------
Shares Outstanding (Basic)
665544
Shares Outstanding (Diluted)
665544
Shares Change
11.52%18.42%0.30%11.46%0.97%14.99%
EPS (Basic)
-7.84-7.61-8.25-15.19-8.61-7.89
EPS (Diluted)
-7.84-7.61-8.25-15.19-8.61-7.89
EPS Growth
------

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
--37.53-32.3-55.21-23.84-33.59
Free Cash Flow Per Share
--6.80-6.93-11.88-5.72-8.14
Gross Margin
84.82%68.99%66.95%52.28%77.21%81.41%
Operating Margin
-1376.13%-936.33%-246.24%-553.11%-418.91%-823.88%
Profit Margin
-1393.00%-901.22%-242.82%-534.69%-391.94%-817.16%
Free Cash Flow Margin
--805.36%-204.12%-418.22%-260.32%-842.60%
EBITDA
-42.31-39.27-33.91-67.58-31.27-25.49
EBITDA Margin
---214.27%---
D&A For EBITDA
3.484.375.065.447.097.36
EBIT
-45.78-43.63-38.97-73.02-38.36-32.84
EBIT Margin
---246.24%---